Articles
The effectiveness of the Rotigotine Transdermal Patch in Parkinson’s Disease along with Clinical Cases
Published 2025-12-03
Keywords
- levodopa,
- monotherapy,
- receptors,
- placebo,
- rotigotine
How to Cite
Banerjee, Souradeep, et al. “The Effectiveness of the Rotigotine Transdermal Patch in Parkinson’s Disease Along With Clinical Cases”. Swami Vivekananda University Press, Dec. 2025, pp. 238-52, https://swamivivekanandauniversitypress.com/index.php/svup/article/view/182.
Copyright (c) 2025 Swami Vivekananda University Press

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Abstract
Rotigotine, a non-ergot dopamine receptor agonist targeting D3/D2/D1 receptors, is administered through a transdermal delivery system which has been studied for managing idiopathic Parkinson’s disease.
DOI - https://doi.org/10.65525/SVUP.9788198800473.2025.238-252